Pricing

Log inSign up

Wugen

0 followers

‌

Wugen is a clinical stage immuno-oncology cell therapy company, developing off-the-shelf NK and CAR-T cell therapies for the treatment of both solid tumor and heme malignancies.

Industries

Biotechnology

Headquarters

St. Louis, United States

Employees

51-200

Links

Org chart

Kumar Srinivasan
President & CEO
Collapse
Ayman Kabakibi
COO & EVP, R&D
CZ
Chupei Zhang
Director
Laura Simpson PhD
Vp, Head Of Regulatory Affairs
MC
Matthew Cooper
Chief Scientific Officer
Patrick Valme
Director Of Information Technology
Preeta Dasgupta
Senior Director Regulatory Affairs
Keith Vendola
Chief Financial Officer

Board & advisors

MA
Mark Alles
Chair
NM
Natalie Mount
Director
John McKearn
Director
Drew Dennison
Director
KL
Kevin Li
Director
BM
Bali Muralidhar
Director
BH
Bosun Hau
Director
Peter Kiener
Director
Todd Fehniger
Advisor
KH
Katharine Hsu
Advisor
JM
Jeffrey Miller,
Advisor
WQ
Waseem Qasim
Advisor
Melissa Berrien-Elliott
Scientific Founder

Teams

BT
+14

Research and Development Scientists

18 people · 0 jobs

+2

Clinical and Regulatory Affairs

6 people · 0 jobs

Leadership Team

2 people · 0 jobs

ES
+1

Research and Development

5 people · 0 jobs

+1

Finance and Operations

5 people · 0 jobs

JM
KH
WQ

Advisory Roles

4 people · 0 jobs

Offices

Similar companies

Sutro Biopharma

3 followers

Active Motif

3 followers

Dyno Therapeutics

4 followers

Janux Therapeutics

1 follower

Eikon Therapeutics

3 followers

Gilead Sciences

158 followers

Regeneron

124 followers

Illumina

78 followers

Agilent Technologies

78 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

44 followers

Explore companies